CN201977965U - Lacrimal canaliculi stent - Google Patents

Lacrimal canaliculi stent Download PDF

Info

Publication number
CN201977965U
CN201977965U CN 201120061801 CN201120061801U CN201977965U CN 201977965 U CN201977965 U CN 201977965U CN 201120061801 CN201120061801 CN 201120061801 CN 201120061801 U CN201120061801 U CN 201120061801U CN 201977965 U CN201977965 U CN 201977965U
Authority
CN
China
Prior art keywords
stent
lacrimal canaliculi
lacrimal
stay pipe
canaliculi
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN 201120061801
Other languages
Chinese (zh)
Inventor
沈素民
李力
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
2nd Affiliated Hospital of Nanjing Medical University
Original Assignee
2nd Affiliated Hospital of Nanjing Medical University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 2nd Affiliated Hospital of Nanjing Medical University filed Critical 2nd Affiliated Hospital of Nanjing Medical University
Priority to CN 201120061801 priority Critical patent/CN201977965U/en
Application granted granted Critical
Publication of CN201977965U publication Critical patent/CN201977965U/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Landscapes

  • Prostheses (AREA)

Abstract

The utility model relates to ophthalmosurgery surgical equipment, in particular to a lacrimal canaliculi stent, which is used for supporting and communicating the lacrimal canaliculi of a patient. The lacrimal canaliculi stent is characterized by comprising a support tube (1),the support tube (1) is a cylindrical tubular structure with two through ends, and a ball sac (2) is disposed on the support tube (1). The lacrimal canaliculi stent can realize full support, expansion and drainage effect on the body of the lacrimal canaliculi of the patient. By the aid of the lacrimal canaliculi stent, liquid medicine is more effective in an irrigation function, fester and lesion positions can be directly irrigated, and the liquid medicine can be added in a more concentrative manner. The lacrimal canaliculi stent can be widely applied to blockage due to inflammation, is used as a main method for treating lacrimal canaliculi rupture caused by trauma, can realize supporting and bridging efficacy and greatly improves permanent success rate of surgeries. In addition, tube arrangement for the lacrimal canaliculi stent can be easily implemented, surgical risks are low, the lacrimal canaliculi stent can be fixed in a buried suture manner, barbs, the ball sack and a structure consisting of two larger ends and a smaller middle portion can be disposed on the lacrimal canaliculi stent so as to prevent the lacrimal canaliculi stent from slipping and being blocked.

Description

The lacrimal ductule support
Technical field
This utility model relates to the eye surgery device, especially a kind of lacrimal ductule support that is used for lacrimal ductule support, conducting.
Background technology
A pipeline is arranged between people's canthus and the nasal cavity, be called lacrimal passage, be made up of puncta, lacrimal ductule body, tear house steward, lachrymal sac, nasolacrimal duct from top to bottom, its function is the drain tear.If lacrimal passage stops up because of reasons such as narrow, inflammation, wounds, tear drainage is obstructed, a large amount of tears is accumulated in the lachrymal sac, will cause multiplying in a large number of antibacterial, thereby cause chronic dacryocystitis, find that through the lacrimal passage splanchnoscopy reason of lacrimal passage postoperative recurrence is needed badly and in time taked the associated treatment measure based on granulation and hypertrophy.
Laceration of lacrimal canaliculus is one of common ocular injury emergency case, and the lacrimal ductule of surgical stapling fracture is the only method of this emergency case of treatment.The nasolacrimal anastomosis method of report is multiple at present, and the lacrimal ductule supporter also has lumbar anesthesia pipe, silica gel tube silk thread etc. to have nothing in common with each other.
The ring-type tissue that the lacrimal ductule broken ends of fractured bone is white in color, make the lacrimal ductule supporter with the lumbar anesthesia pipe and have many drawbacks, the lumbar anesthesia pipe is thinner, and the lacrimal ductule broken ends of fractured bone is difficult for being close to and sewing up, and also bring difficulty for corresponding stitching of endocanthion portion, put Guan Houhui and find to cause eversion of lacrimal punctum, laceration of canaliculus.Though silica gel tube is soft, be difficult for putting pipe, slippage easily.
Because the special physiological structure of lacrimal ductule, the thin and inside of its tube chamber does not have skeleton to support, and after pipe was put in operation, the soft tissues such as granulation, cicatrix of very easily growing resulted in blockage.
Summary of the invention
The purpose of this utility model is to overcome above-mentioned defective, and a kind of lacrimal ductule support is provided.
The technical solution of the utility model is:
A kind of lacrimal ductule support, it comprises stay pipe, described stay pipe is the cylindrical tubular structure that two ends connect.
Described stay pipe is provided with sacculus.
Described stay pipe one end is provided with horn mouth.
Two ports of described stay pipe are respectively equipped with a horn mouth.
The outer wall of described stay pipe is provided with one or more projection granules.
Described stay pipe is provided with agnail.
Described stay pipe is provided with wears fairlead.
The beneficial effects of the utility model are:
1, this utility model is one-body molded makes, simple for production, bulk strength height, long service life;
2, this utility model can play the omnidistance expansion drainage that supports to the lacrimal ductule body;
3, this utility model makes that in use the flushing action of medicinal liquid is more effective, can directly wash the suppuration diseased region, makes applying of medicinal liquid concentrated, can directly effectively arrive areas of inflammation;
4, of the present utility modelly can prevent to injure cornea, the uncomfortable disease after having avoided causing pathological changes and having put pipe has effectively improved patient's comfort level.
5, when settling lacrimal ductule support of the present utility model, the end of draught line can be lain in the fairlead of wearing of lacrimal ductule support end, just lacrimal ductule support of the present utility model can be delivered to assigned address, highly effective and safe smoothly.
6, lacrimal ductule support of the present utility model can be widely used in the obstruction that inflammation causes, causes the main means of laceration of lacrimal canaliculus as wound, and the effect of can bring into play support, putting up a bridge improves the permanent success rate of operation greatly.
7, lacrimal ductule of the present utility model props up and mounts pipe easily, and operation risk is little, can adopt the mode of sunkening cord to fix, and the little structure in the big centre in agnail, sacculus and two can be set on it, can effectively prevent slippage and obstruction,
8, lacrimal ductule support of the present utility model reproduces with lacrimal point applicable to lacrimal ductule and reproduces.
Description of drawings
Fig. 1 is the structural representation of this utility model embodiment one.
Fig. 2 is the structural representation of this utility model embodiment two.
Fig. 3 is the structural representation of this utility model embodiment three.
Fig. 4 is the structural representation of this utility model embodiment four.
Fig. 5 is the structural representation of this utility model embodiment five.
Fig. 6 is the structural representation of this utility model embodiment six.
Fig. 7 is the structural representation of this utility model embodiment seven.
Among the figure: 1 is that stay pipe, 2 is that sacculus, 3 is that horn mouth, 4 is that projection granule, 5 is that agnail, 6 is for wearing fairlead.
The specific embodiment
Below in conjunction with accompanying drawing this utility model is further described:
As Fig. 1, a kind of lacrimal ductule support, it comprises stay pipe 1, the cylindrical tubular structure that described stay pipe 1 connects for two ends.Stay pipe 1 is provided with sacculus 2.
As Fig. 2, a kind of lacrimal ductule support, it comprises stay pipe 1, the cylindrical tubular structure that described stay pipe 1 connects for two ends.Stay pipe 1 one ends are provided with horn mouth 3.
As Fig. 3, a kind of lacrimal ductule support, it comprises stay pipe 1, the cylindrical tubular structure that described stay pipe 1 connects for two ends.Two ports of stay pipe 1 are respectively equipped with a horn mouth 3.
As Fig. 4, a kind of lacrimal ductule support, it comprises stay pipe 1, the cylindrical tubular structure that described stay pipe 1 connects for two ends.The outer wall of stay pipe 1 is provided with two symmetric projection granules 4.
As Fig. 5, a kind of lacrimal ductule support, it comprises stay pipe 1, the cylindrical tubular structure that described stay pipe 1 connects for two ends.The outer wall of stay pipe 1 is provided with the projection granule 4 of a plurality of asymmetric settings.
As Fig. 6, a kind of lacrimal ductule support, it comprises stay pipe 1, the cylindrical tubular structure that described stay pipe 1 connects for two ends.Stay pipe 1 is provided with agnail 5.
As Fig. 7, a kind of lacrimal ductule support, it comprises stay pipe 1, the cylindrical tubular structure that described stay pipe 1 connects for two ends.Stay pipe 1 is provided with wears fairlead 6.
Lacrimal ductule support of the present utility model according to the difference of timbering material, can be divided into 316L stainless steel stent, nickel support, tantalum support and silica gel support etc.
Ideal support should possess following feature: flexibly, good biocompatibility, reliable, the good supporting force of spreading performance.
Lacrimal ductule support of the present utility model can be expanded lacrimal ductule to the utmost, is to plant line in advance than being easier to also, is beneficial to the lacrimal ductule healing.Laceration of lacrimal canaliculus is clinical common ophthalmology emergency case, will cause the tear that overflows throughout one's life if can not in time find lacrimal ductule also to coincide.The finding method of the lacrimal ductule broken ends of fractured bone is very many, such as pigtail hook, adhered elastomer, stain, milk etc.It is very effective to find that in clinical practice the direct exposure method that adopts lacrimal ductule support of the present utility model to cooperate the suture traction is sought the laceration of lacrimal canaliculus end, uses the lead-in wire silica gel tube as support simultaneously, receives extraordinary curative effect.

Claims (7)

1. a lacrimal ductule support is characterized in that it comprises stay pipe (1), the cylindrical tubular structure that described stay pipe (1) connects for two ends.
2. lacrimal ductule support according to claim 1 is characterized in that described stay pipe (1) is provided with sacculus (2).
3. lacrimal ductule support according to claim 1 is characterized in that described stay pipe (1) one end is provided with horn mouth (3).
4. lacrimal ductule support according to claim 1 is characterized in that two ports of described stay pipe (1) are respectively equipped with a horn mouth (3).
5. lacrimal ductule support according to claim 1 is characterized in that the outer wall of described stay pipe (1) is provided with one or more projection granules (4).
6. lacrimal ductule support according to claim 1 is characterized in that described stay pipe (1) is provided with agnail (5).
7. lacrimal ductule support according to claim 1 is characterized in that described stay pipe (1) is provided with to wear fairlead (6).
CN 201120061801 2011-03-10 2011-03-10 Lacrimal canaliculi stent Expired - Fee Related CN201977965U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 201120061801 CN201977965U (en) 2011-03-10 2011-03-10 Lacrimal canaliculi stent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 201120061801 CN201977965U (en) 2011-03-10 2011-03-10 Lacrimal canaliculi stent

Publications (1)

Publication Number Publication Date
CN201977965U true CN201977965U (en) 2011-09-21

Family

ID=44605436

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 201120061801 Expired - Fee Related CN201977965U (en) 2011-03-10 2011-03-10 Lacrimal canaliculi stent

Country Status (1)

Country Link
CN (1) CN201977965U (en)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105534640A (en) * 2015-07-28 2016-05-04 李雷 Operation device and probe for fracture lacrimal duct anastomosis and lacrimal stent synchronous implanting
CN107669381A (en) * 2017-11-29 2018-02-09 成都创客之家科技有限公司 A kind of medicament-release blood vessel stent
CN107669380A (en) * 2017-11-29 2018-02-09 成都创客之家科技有限公司 A kind of drug eluting vascular support
CN107693163A (en) * 2017-11-29 2018-02-16 成都创客之家科技有限公司 One kind can develop intravascular stent
CN107744414A (en) * 2017-11-29 2018-03-02 成都创客之家科技有限公司 A kind of film-coated vascular support
CN107744415A (en) * 2017-11-29 2018-03-02 成都创客之家科技有限公司 A kind of titanium alloy carries medicine intravascular stent
CN107753163A (en) * 2017-11-29 2018-03-06 成都创客之家科技有限公司 A kind of anti-skidding intravascular stent
CN107753149A (en) * 2017-11-29 2018-03-06 成都创客之家科技有限公司 A kind of intravascular stent with developing function
CN107802377A (en) * 2017-11-29 2018-03-16 成都创客之家科技有限公司 A kind of titanium alloy film-coated vascular support
CN107802385A (en) * 2017-11-29 2018-03-16 成都创客之家科技有限公司 A kind of titanium alloy intravascular stent
CN107981969A (en) * 2017-12-29 2018-05-04 温州医科大学附属眼视光医院 Drainage substitutes biomimetic scaffolds in a kind of glaucoma

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105534640A (en) * 2015-07-28 2016-05-04 李雷 Operation device and probe for fracture lacrimal duct anastomosis and lacrimal stent synchronous implanting
CN107669381A (en) * 2017-11-29 2018-02-09 成都创客之家科技有限公司 A kind of medicament-release blood vessel stent
CN107669380A (en) * 2017-11-29 2018-02-09 成都创客之家科技有限公司 A kind of drug eluting vascular support
CN107693163A (en) * 2017-11-29 2018-02-16 成都创客之家科技有限公司 One kind can develop intravascular stent
CN107744414A (en) * 2017-11-29 2018-03-02 成都创客之家科技有限公司 A kind of film-coated vascular support
CN107744415A (en) * 2017-11-29 2018-03-02 成都创客之家科技有限公司 A kind of titanium alloy carries medicine intravascular stent
CN107753163A (en) * 2017-11-29 2018-03-06 成都创客之家科技有限公司 A kind of anti-skidding intravascular stent
CN107753149A (en) * 2017-11-29 2018-03-06 成都创客之家科技有限公司 A kind of intravascular stent with developing function
CN107802377A (en) * 2017-11-29 2018-03-16 成都创客之家科技有限公司 A kind of titanium alloy film-coated vascular support
CN107802385A (en) * 2017-11-29 2018-03-16 成都创客之家科技有限公司 A kind of titanium alloy intravascular stent
CN107981969A (en) * 2017-12-29 2018-05-04 温州医科大学附属眼视光医院 Drainage substitutes biomimetic scaffolds in a kind of glaucoma
CN107981969B (en) * 2017-12-29 2023-07-14 苏州朗目医疗科技有限公司 Replacement bionic bracket for glaucoma internal drainage

Similar Documents

Publication Publication Date Title
CN201977965U (en) Lacrimal canaliculi stent
CN103932841B (en) One is executed Lai Mushi and is managed (Schlemm) expandable stent and assembly thereof
US20070185468A1 (en) Method for fluid control in medical applications
US20220240982A1 (en) Uterine hemorrhage controlling system and method
WO2006058189A3 (en) Medical device for temperature control and treatment of the eye and surrounding tissues
CN103111010A (en) Double-cavity sacculus tube and application thereof
US20200352602A1 (en) Uterine hemorrhage controlling system and method
JP7384494B2 (en) Collapsible top press balloon structure
RU2394533C1 (en) Method of surgical treatment of retinal detachment
Rabbani et al. Traumatic rupture of tympanic membrane: A study of 70 cases
CN202637196U (en) Lacrimal passage support with adjustable thickness
CN202128573U (en) Special tubular bracket for lacrimal passage minimally invasive surgery
CN205849639U (en) A kind of scalable Glaucoma Drainage pipe
Eloy et al. Endonasal endoscopic dacryocystorhinostomy for a primary dacryocystocele in an adult.
CN210170282U (en) Drainage device for vitreous cavity hematocele of ophthalmology department
CN110302005B (en) Posterior sclera quantitative pressurizing block and application method thereof
RU2395255C1 (en) Method of surgical treatment of through idiopathic macular rupture
CN107569277A (en) Fibroid extracts system under the laparoscope of palace
Viswanatha et al. Silicone stenting and polypropylene stenting in endoscopic dacryocystorhinostomy: A prospective comparative study
RU2421165C1 (en) Method of preventing stenosis of frontonasal fistula in surgical treatment of chronic frontitis
RU139441U1 (en) BINARY STENT FOR THE FORMATION OF THE JUSTON WITH EXTERNAL DACRIOCISTORINOSTOMY
Hakim et al. Silicone intubation with trans-sac fixation to prevent tube dislocation
CN101015486A (en) Supporting artificial tube
CN209611444U (en) Band umbrella Lacrimal canaliculi stent
CN202128572U (en) Support specialized for minimal invasive lacrimal surgery with fixed supporting feet and tubular bracket

Legal Events

Date Code Title Description
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20110921

Termination date: 20140310